Gordian Biotechnology
Gordian Biotechnology is a therapeutics company focused on diseases of aging, the major unmet medical need of our generation.
Age-related diseases have complex etiologies that depend on interactions with the aged environment, and traditional ex vivo screening methods have failed to produce effective treatments. To address this problem, Gordian’s platform simultaneously delivers and tests hundreds of therapeutics in individual animals. We thus scale in vivo efficacy testing to cover every therapeutic target at the very beginning of the drug discovery process. This lets us choose targets that really impact disease biology, to develop and commercialize efficacious therapies for the world’s deadliest diseases.
Moreover, our screening is designed to generate vast datasets with every run, even while we directly identify therapeutics. This enables our data analysis pipeline to map out the underlying biology causing disease, and even the fundamental processes of aging itself